The Space Stock With a Much Bigger Opportunity Than Launches

Impact · against what's priced in

Rocket Lab's announcement of $1 billion in new Q3 contracts provides fresh revenue visibility that the market has not yet baked in. Other catalysts, including the Iridium acquisition and Neutron's path to EBITDA positivity, are already largely reflected in the stock's rejection of analyst price targets.

RKLB+0.30: Not in the price yet
The price assumes: The full $2.36 billion backlog converting to revenue

The Space Stock With a Much Bigger Opportunity Than Launches

What matters in this story

Eli Lilly Jumped 6% After Earnings. It's Up 68% in a Year.

The Space Stock With a Much Bigger Opportunity Than Launches

What matters in this story

Eli Lilly Jumped 6% After Earnings. It's Up 68% in a Year.

How each ticker is affected

Connected tickers

Track these names every morning.

Can CAH's Specialty Strength Offset Medical Distribution Challenges in Q1?

Flex Stock Down Post Q2 Earnings: Should You Buy, Hold or Offload?

AAR announces proposed offering of $955 million of senior notes due 2031 and $960 million of senior notes due 2034

Sirius XM: Green Shoots Confirm Bull Thesis

The Space Stock With a Much Bigger Opportunity Than Launches

What matters in this story

Next reads from the same story arc

Eli Lilly Jumped 6% After Earnings. It's Up 68% in a Year.

The Space Stock With a Much Bigger Opportunity Than Launches

What matters in this story

Next reads from the same story arc

Eli Lilly Jumped 6% After Earnings. It's Up 68% in a Year.

How each ticker is affected

Connected tickers

Track these names every morning.

Can CAH's Specialty Strength Offset Medical Distribution Challenges in Q1?

Flex Stock Down Post Q2 Earnings: Should You Buy, Hold or Offload?

AAR announces proposed offering of $955 million of senior notes due 2031 and $960 million of senior notes due 2034

Sirius XM: Green Shoots Confirm Bull Thesis